Clinical Trial: Empagliflozin and CPAP in Adults With Heart Failure and Obstructive Sleep Apnea.

U.S., April 30 -- ClinicalTrials.gov registry received information related to the study (NCT07556094) titled 'Empagliflozin and CPAP in Adults With Heart Failure and Obstructive Sleep Apnea.' on April 15.

Brief Summary: The goal of this randomized clinical trial was to evaluate the effects of empagliflozin, a sodium-glucose cotransporter-2 inhibitor (SGLT2i) on sleep and cardiac outcomes in adults with heart failure (HF) and obstructive sleep apnea syndrome (OSA). The study also examined how subsequent initiation of continuous positive airway pressure (CPAP) therapy affected sleep and cardiac outcomes, and whether response to treatment differed according to baseline obstructive sleep apnea severity.

The main questions it aims to answer we...